Risk-MaPP provides a scientific risk-based approach, based on ICH Q9 Quality Risk Management, to manage the risk of cross contamination in order to achieve and maintain an appropriate balance between product quality and operator safety. Find this definition and more in the ISPE Glossary of Pharmaceutical Technology.
Risk-MaPP Resources
Opportunities to understand the “why”, “what”, and “how to use” the Guide include conferences, webinars, training, and white papers. Educational sessions pertaining to Risk-MaPP will focus on use of the logic diagram, how health based limits are developed, setting cleaning validation limits, risk assessments for cross contamination, and formulating a Quality Risk Management Plan as part of a Quality System. See below for more information on Risk-MaPP.
- Risk-MaPP Blog
In response to industry needs, ISPE has set up a blog dedicated to the issues related to the new Risk-MaPP Baseline Guide. This blog will allow industry to keep abreast of the latest regulatory thinking in regards to Risk-MaPP and managing the risk of cross-contamination as well as a forum to share experiences in implementing the principles in multi-product facilities and to seek advice and answers in the use of the guide. Come join the discussion!
- Risk-MaPP FAQs
ISPE has created an FAQ document dedicated to frequently asked questions on Risk-MaPP and its approach to managing the risk of cross contamination. The first version of this document highlights questions around limit setting which were raised during the some of the launch sessions in the fall. This document will be updated as needed to include other frequent questions as they arise. This is a must have complement to your Risk-MaPP guide.
Webinars
Knowledge Briefs and White Papers
Articles

Indicates content available to ISPE members only.
Last Update: 26 September 2011